Want to see AU:NEU full AI Analyst Report?
Neuren Pharmaceuticals Limited (NEU) Ownership - Who Owns Neuren Pharmaceuticals Limited?
Neuren Pharmaceuticals Limited (NEU) Ownership Overview
- 0.04% Insiders
- 3.16% Mutual Funds
- <0.01% Other Institutional Investors
- 5.94% ETFs
- 90.86% Public Companies and Individual Investors
The ownership structure of Neuren Pharmaceuticals Limited (AU:NEU) stock is a mix of institutional, retail, and individual investors. Approximately 9.10% of the company’s stock is owned by Institutional Investors, 0.04% is owned by Insiders, and 90.86% is owned by Public Companies and Individual Investors.
The ownership structure of Neuren Pharmaceuticals Limited (AU:NEU) stock is a mix of institutional, retail, and individual investors. Approximately 9.10% of the company’s stock is owned by Institutional Investors, 0.04% is owned by Insiders, and 90.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 05, 2026 | Joseph Basile | AU$151,782 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 3,371,153 | Institution | 2.66% | 48,244,571 |
| Ishares | 2,418,103 | Institution | 1.91% | 34,605,472 |
| Vanguard Star Funds | 1,601,911 | Institution | 1.26% | 22,924,948 |
| Vanguard Tax-managed Funds | 1,071,677 | Institution | 0.85% | 15,336,770 |
| Avantis | 936,996 | Institution | 0.74% | 13,409,350 |
| Vanguard International Equity Index Funds | 658,743 | Institution | 0.52% | 9,427,271 |
| Dimensional | 300,966 | Institution | 0.24% | 4,307,124 |
| Schwab | 226,763 | Institution | 0.18% | 3,245,205 |
| Investment Managers Series Trust | 199,264 | Institution | 0.16% | 2,851,667 |
| Clearwater Investment Trust | 159,483 | Institution | 0.13% | 2,282,361 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 1,601,911 | Institution | 1.26% | 22,924,948 |
| Vanguard Tax-managed Funds | 1,071,677 | Institution | 0.85% | 15,336,770 |
| Vanguard International Equity Index Funds | 658,743 | Institution | 0.52% | 9,427,271 |
| Investment Managers Series Trust | 199,264 | Institution | 0.16% | 2,851,667 |
| Clearwater Investment Trust | 159,483 | Institution | 0.13% | 2,282,361 |
| Dfa Investment Dimensions Group Inc | 129,690 | Institution | 0.10% | 1,855,994 |
| Fidelity Salem Street Trust | 65,478 | Institution | 0.05% | 937,056 |
| Goldman Sachs Trust | 33,432 | Institution | 0.03% | 478,445 |
| Fidelity Concord Street Trust | 33,092 | Institution | 0.03% | 473,580 |
| State Street Institutional Investment Trust | 32,616 | Institution | 0.03% | 466,768 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard, VXUS ETF | 1,615,339 | Institution | 1.27% | 22,666,955 |
| Vanguard, VEA ETF | 1,069,259 | Institution | 0.84% | 15,004,182 |
| iShares, IEFA ETF | 879,396 | Institution | 0.69% | 12,530,357 |
| Avantis, AVDV ETF | 697,766 | Institution | 0.55% | 9,918,245 |
| Vanguard, VSS ETF | 405,833 | Institution | 0.32% | 5,694,778 |
| iShares, SCZ ETF | 403,620 | Institution | 0.32% | 5,751,110 |
| iShares, IDEV ETF | 245,491 | Institution | 0.19% | 3,497,958 |
| Schwab, SCHC ETF | 226,763 | Institution | 0.18% | 3,214,488 |
| iShares, IXUS ETF | 167,280 | Institution | 0.13% | 2,377,766 |
| Dimensional, DFIS ETF | 165,625 | Institution | 0.13% | 2,208,473 |
FAQ
Who Owns Neuren Pharmaceuticals Limited (AU:NEU)?
According to the latest TipRanks data, approximately 9.10% of the company's stock is held by institutional investors, 0.04% is held by insiders, and 90.86% is held by public companies and individual investors.
What percentage of Neuren Pharmaceuticals Limited (AU:NEU) stock is held by institutional investors?
According to the latest TipRanks data, approximately 9.10% of Neuren Pharmaceuticals Limited (AU:NEU) stock is held by institutional investors: 3.16% by mutual funds, 5.94% by ETFs and <0.01% by other institutional investors.
What percentage of Neuren Pharmaceuticals Limited (AU:NEU) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.86% of Neuren Pharmaceuticals Limited (AU:NEU) stock is held by public companies and individual investors.
Who owns the most shares of Neuren Pharmaceuticals Limited (AU:NEU)?
Vanguard owns the most shares of Neuren Pharmaceuticals Limited (AU:NEU).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.